[1]
|
International Diabetes Federation (2021) IDF Diabetes Atlas. 10th Edition, International Diabetes Federation, Brus-sels.
|
[2]
|
Purrello, F. and Rabuazza, A.M. (2000) Metabolic Factors That Affect Beta-Cell Function and Survival. Dia-betes Nutrition & Metabolism, 13, 84-91.
|
[3]
|
Toschi, E., Camastra, S., Sironi, A.M., Masoni, A., Gastaldelli, A., Mari, A., et al. (2002) Effect of Acute Hyperglycemia on Insulin Secretion in Humans. Diabetes, 51, S130-S133. https://doi.org/10.2337/diabetes.51.2007.S130
|
[4]
|
Hsieh, C.H., Hung, Y.J., He, C.T., Lee, C.H., Hung, S.C., Wang, Y.K., et al. (2005) The Capability of Glucose Toxicity on Severe Type 2 Diabetes. Endocrine Research, 31, 149-158. https://doi.org/10.1080/07435800500320661
|
[5]
|
Ilkova, H., Glaser, B., Tunckale, A., Bagriaçik, N. and Cerasi, E. (1997) Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin Treatment. Diabetes Care, 20, 1353-1356.
https://doi.org/10.2337/diacare.20.9.1353
|
[6]
|
中国胰岛素分泌研究组. 短期胰岛素强化治疗逆转2型糖尿病专家共识[J]. 中华糖尿病杂志, 2021, 13(10): 949-959.
|
[7]
|
Stein, C.M., Kramer, C.K., Zinman, B., Choi, H., Op-steen, C. and Retnakaran, R. (2015) Clinical Predictors and Time Course of the Improvement in ß-Cell Function with Short-Term Intensive Insulin Therapy in Patients with Type 2 Diabetes. Diabetic Medicine, 32, 645-652. https://doi.org/10.1111/dme.12671
|
[8]
|
周广举, 崔佳乐, 李宜臻, 崔素芬, 谢素华, 杨秋, 等. 胰岛素短期强化治疗后不同治疗方案对2型糖尿病患者血糖控制水平及其相关指标的影响[J]. 中国医药, 2019, 14(12): 1813-1817.
|
[9]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
[10]
|
郎名丽. 胰岛素泵在老年2型糖尿病患者中的临床疗效观察[J]. 中国现代药物应用, 2019, 13(12): 87-89.
|
[11]
|
刘昱. 胰岛素泵强化治疗对新诊断2型糖尿病患者血糖及胰岛β细胞功能的影响[J]. 实用糖尿病杂志, 2019, 15(5): 15-16.
|
[12]
|
何继东, 姚荷玲, 张兰, 兰直良, 童学良, 刘莉. 新诊断2型糖尿病患者早期胰岛素泵强化治疗时间选择[J]. 中华临床医师杂志, 2015, 9(10): 202-205.
|
[13]
|
Kramer, C.K., Zinman, B. and Retnakaran, R. (2013) Short-Term Intensive Insulin Therapy in Type 2 Diabetes Mellitus: A Systematic Review and Me-ta-Analysia. The Lancet Diabetes & Endocrinology, 1, 28-34.
https://doi.org/10.1016/S2213-8587(13)70006-8
http://www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70006-8/fulltext
|
[14]
|
张喜婷, 刘莉娟, 曾维伟, 张波, 周梅清, 刘双. 短期胰岛素泵强化治疗联合自我血糖监测对新诊断2型糖尿病患者血糖控制的评价[J]. 中国糖尿病杂志, 2018, 26(12): 998-1003.
|
[15]
|
周立新, 杨晶, 孙荃, 冯晨秋, 赵芳. 722型和712型胰岛素泵用于初诊2型糖尿病患者的降糖效果和焦虑、抑郁情绪的比较[J]. 中华糖尿病杂志, 2017, 9(4): 248-250.
|
[16]
|
Pickup, J.C. (2014) Diabetes: Insulin Pump Therapy for Type 2 Diabetes Mellitus. Nature Reviews Endocrinology, 10, 647-649. https://doi.org/10.1038/nrendo.2014.142
|
[17]
|
Lv, W., Li, L., Wen, J., Pan, R.F., Sun, R.X., Wang, J., et al. (2013) Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients. International Journal of Endocrinology, 2013, Article ID: 614242. https://doi.org/10.1155/2013/614242
|
[18]
|
李小景, 荣秀花, 欧宇苹, 张莉. 利拉鲁肽与胰岛素泵治疗超重2型糖尿病的疗效与安全性[J]. 中国医学创新, 2019, 16(27): 35-38.
|
[19]
|
李超杰, 陈慧敏, 濮先明. 利拉鲁肽联合胰岛素强化治疗难治性2型糖尿病的临床疗效观察[J]. 青岛医药卫生, 2019, 51(4): 256-259.
|
[20]
|
姚琪, 李宝新, 郭淑芹, 常文龙, 王翯, 张灿, 等. 不同体重指数2型糖尿病患者血清甘丙肽水平的变化[J]. 临床内科杂志, 2018, 35(4): 246-249.
|
[21]
|
Hernandez, C., Lesser, K. and Reed, K. (2018) Pregnancy Outcomes in an Obstetrical Type I Dia-betic Patient Population, Insulin Pump vs Insulin Injections. Obstetrics & Gynecology, 131, 179-180.
https://doi.org/10.1097/01.AOG.0000533198.43745.05
|
[22]
|
张丽, 张冉, 田领, 勾艳丽, 于征. 通心络胶囊联合胰岛素治疗早期糖尿病肾病的临床观察[J]. 南昌大学学报(医学版), 2016, 56(1): 74-76.
|
[23]
|
李日明. 2型糖尿病并非酒精性肝硬化患者胰岛素强化治疗的相关性探讨[J]. 临床医学工程, 2014, 21(10): 1271.
|